MEDICINE SCIENCE AND EDUCATION,
Journal Year:
2023,
Volume and Issue:
36, P. 53 - 61
Published: Nov. 1, 2023
From
2019
to
2023,
the
global
population
experienced
a
period
characterized
by
outbreak
of
coronavirus
pandemic,
which
was
attributed
SARS-CoV-2
virus.
Cognitive
impairment,
particularly
memory
loss,
is
frequently
reported
individuals
who
have
recovered
from
Covid-19,
alongside
other
neurological
symptoms.
This
phenomenon
not
only
carries
implications
for
individual
health,
but
also
extends
social
and
economic
domains.
garners
interest
scholars.
Numerous
empirical
investigations
established
correlation
between
COVID-19
pandemic
mental
health
disorders.
The
infection
caused
has
been
associated
with
manifestation
psychiatric
Additionally,
pre-existing
illness
are
more
susceptible
experiencing
severe
outcomes
COVID-19,
increased
mortality
rates,
enduring
residual
symptoms
over
an
extended
time.
Dementia
itself
encompasses
multitude
risk
factors,
including
limited
advanced
age,
vascular
metabolic
disorders,
obesity,
hypodynamic
lifestyle,
various
infections,
depression,
smoking
isolation.
These
factors
should
be
considered
collectively
when
evaluating
cognitive
impairment
following
infection.
Nevertheless,
it
obvious
that
survivors
experience
concerns
related
memory,
attention,
perception,
domains,
necessitating
thorough
assessment
and,
in
certain
cases,
intervention.
Given
frequency
“memory
decline”
post-Covid
period,
especially
young
middle
evident
dysfunction
can
detrimental
effects
on
both
quality
life
ability
perform
daily
tasks
efficiently.
In
summary,
existing
literature
review
indicates
lack
comprehensive
understanding
regarding
impact
impairment.
Consequently,
there
pressing
need
further
research
endeavors
focused
specific
nature.
BMC Psychiatry,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Feb. 6, 2024
Post
COVID-19
syndrome,
also
known
as
"Long
COVID,"
is
a
complex
and
multifaceted
condition
that
affects
individuals
who
have
recovered
from
SARS-CoV-2
infection.
This
systematic
review
meta-analysis
aim
to
comprehensively
assess
the
global
prevalence
of
depression,
anxiety,
sleep
disorder
in
coping
with
syndrome.
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Dec. 11, 2023
Post-acute
sequelae
SARS-CoV-2
(PASC),
also
known
as
Long
COVID,
is
a
complex
and
widely
recognized
illness
with
estimates
ranging
from
5
to
30%
of
all
COVID-19
cases.
We
performed
retrospective
chart
review
patients
who
presented
dedicated
Post-COVID-19
clinic
between
June
2021
May
2022.
The
median
patient
age
was
44.5
years,
63.5%
were
female,
at
10.4
months
acute
COVD-19
infection.
78%
self-identified
their
race
white,
21%
identified
Latino
ethnicity.
During
the
infection,
50%
experienced
moderate
disease
severity
10.5%
hospitalized.
top
three
co-morbid
conditions
prior
infection
included
mental
health
conditions,
hypertension
asthma.
Patients
reported
18
new
symptoms
following
illness,
most
common
fatigue
(89%),
forgetfulness
or
"brain
fog"
difficulty
concentrating
(77%).
MoCA
(Montreal
Cognitive
Assessment)
assessment
demonstrated
that
46%
had
mild
cognitive
dysfunction.
PHQ-9
(Patient
Health
Questionnaire)
testing
revealed
42%
severe
depression,
38%
anxiety
on
GAD-7
(Generalized
Anxiety
Disorder)
assessment.
Symptom
burden
similar
across
gender,
age,
initial
severity.
PASC
presenting
an
academic
numerous
multisystem
functional
impairment,
independent
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(7), P. 835 - 835
Published: July 11, 2024
Long
COVID,
a
name
often
given
to
the
persistent
symptoms
following
acute
SARS-CoV-2
infection,
poses
multifaceted
challenge
for
health.
This
review
explores
intrinsic
relationship
between
comorbidities
and
autoimmune
responses
in
shaping
trajectory
of
long
COVID.
Autoantibodies
have
emerged
as
significant
players
COVID-19
pathophysiology,
with
implications
disease
severity
progression.
Studies
show
immune
dysregulation
persisting
months
after
marked
by
activated
innate
cells
high
cytokine
levels.
The
presence
autoantibodies
against
various
autoantigens
suggests
their
potential
comorbid
factors
Additionally,
formation
complexes
may
lead
severe
progression,
highlighting
urgency
early
detection
intervention.
Furthermore,
COVID
is
highly
linked
cardiovascular
complications
neurological
symptoms,
posing
challenges
diagnosis
management.
Multidisciplinary
approaches,
including
vaccination,
tailored
rehabilitation,
pharmacological
interventions,
are
used
mitigating
COVID’s
burden.
However,
numerous
persist,
from
evolving
diagnostic
criteria
addressing
psychosocial
impact
predicting
outcomes.
Leveraging
AI-based
applications
holds
promise
enhancing
patient
management
improving
our
understanding
As
research
continues
unfold,
unravelling
complexities
remains
paramount
effective
intervention
care.
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Jan. 7, 2023
Abstract
Evidence
demonstrating
the
association
of
preexisting
psychiatric
disorders
with
post-COVID-19
is
limited.
We
aim
to
investigate
using
larger
sample
sizes
and
more
extended
postinfection
periods
than
previous
studies.
A
total
6015
(response
rate
=
77.5%)
COVID-19
survivors
were
surveyed
a
self-administered
questionnaire
from
July
September
2021.
Poisson
regression
analysis
robust
error
variance
was
performed
estimate
prevalence
ratios
(PRs)
or
without
disorders.
Participants
numbered
1067
(17.7%),
2149
(35.7%).
Post-COVID-19
PR
1.09
(95%
CI
1.02–1.18,
p
0.013).
The
interaction
between
significant
(p
for
<
0.001).
subgroup
showed
that
those
might
be
at
greater
prolonged
risk
These
findings
suggested
associated
an
increased
risk,
prolong
even
if
time
passes.
Frontiers in Psychiatry,
Journal Year:
2024,
Volume and Issue:
15
Published: Jan. 23, 2024
Background
Coronavirus
disease
2019
(COVID-19)
is
a
global
public
health
concern.
Evidence
shows
that
depression
and
anxiety
are
common
among
patients
with
COVID-19
after
recovery.
About
one-third
of
the
total
cases
in
Bangladesh
have
been
reported
Dhaka
city.
Therefore,
study
aimed
to
evaluate
prevalence
survivors
city
as
well
identify
factors
associated
these
mental
conditions.
Methods
A
cross-sectional
was
carried
out
384
aged
18
years
or
older.
Data
collection
done
through
face-to-face
telephone
interviews
using
semi-structured
questionnaire.
Patient
Health
Questionnaire
(PHQ-9)
Generalized
Anxiety
Disorder
(GAD-7)
scales
were
used
assess
anxiety,
respectively.
Binary
logistic
regression
analysis
performed
predictors
recovered
from
COVID-19.
Results
The
overall
26.0%
23.2%,
respectively
survivors.
respondents
who
≥60
2.62
3.02
times
more
likely
report
depressive
symptoms,
than
those
39
years.
Hospitalised
had
2.18
higher
chance
developing
their
non-hospitalised
counterparts.
comorbidities
at
3.35
2.97
risk
compared
without
comorbidities.
Similarly,
already
passed
period
15
days
3
months
recovery
showed
3.06
1.85
odds
above
6
Conclusion
high
living
findings
suggest
need
for
appropriate
interventions
reduce
complications
Journal of Neuropsychiatry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 7, 2025
The
authors
aimed
to
characterize
the
long-term
psychiatric
outcomes
and
their
predictors
among
survivors
of
autoimmune
encephalitis
(AE).
In
this
retrospective
cohort
study,
patients
diagnosed
as
having
AE
between
2008
2023
at
two
academic
medical
centers
(in
New
York
City
Toronto)
completed
Mini
International
Neuropsychiatric
Interview
7.0.2
(MINI)
Profile
Mood
States
(POMS-2)
assess
outcomes.
Clinical
characteristics
were
assessed
for
potential
Bivariate
analyses
univariate
logistic
regressions
conducted
relationship
primary
outcome.
Overall,
42
participants
(female,
N=26,
62%;
median
age=37.5
years,
interquartile
range
[IQR]=32.8
years)
a
4
years
(IQR=6
after
an
diagnosis.
subtypes
included
anti-N-methyl-d-aspartate
(33%),
anti-leucine-rich-glioma-inactivated
1
(24%),
anti-glutamic
acid
decarboxylase
65
(14%),
antibody-negative
(29%).
total,
71%
who
MINI
met
criteria
DSM-5
diagnosis,
56%
mood
disorder.
Thirteen
(31%)
reported
above-average
total
disturbance
on
POMS-2.
Mann-Whitney
U
tests
revealed
that
disorder
self-reported
significantly
higher
levels
confusion
bewilderment
(z=-2.04,
p=0.04)
depression
dejection
(z=-2.24,
p=0.03)
lower
vigor
activity
(z=-2.62,
p=0.01).
have
high
prevalence
comorbid
conditions,
with
most
being
significant
proportion
endorsing
ongoing
disturbance.
Patients
history
may
benefit
from
closer
follow-up.
Long
COVID,
a
name
often
given
to
the
persistent
symptoms
following
acute
SARS-CoV-2
infection,
poses
multifaceted
challenge
for
health.
This
review
explores
intrinsic
relationship
between
comorbidities
and
autoimmune
responses
in
shaping
trajectory
of
long
COVID.
Autoantibodies
have
emerged
as
significant
players
COVID-19
pathophysiology,
with
implications
disease
severity
progression.
Studies
show
immune
dysregulation
persisting
months
after
marked
by
activated
innate
cells
high
cytokine
levels.
The
presence
autoantibodies
against
various
autoantigens
suggests
their
potential
comorbid
factors
Additionally,
formation
complexes
may
lead
severe
progression,
highlighting
urgency
early
detection
intervention.
Furthermore,
COVID
is
highly
linked
cardiovascular
complications
neurological
symptoms,
posing
challenges
diagnosis
management.
Multidisciplinary
approaches,
including
vaccination,
tailored
rehabilitation,
pharmacological
interventions,
are
used
mitigating
COVID's
burden.
However,
numerous
persist,
from
evolving
diagnostic
criteria
addressing
psychosocial
impact
predicting
outcomes.
Leveraging
AI-based
applications
holds
promise
enhancing
patient
management
improving
our
understanding
As
research
continues
unfold,
unravelling
complexities
remains
paramount
effective
intervention
care.
Background
and
objective:
The
impairments
duration
of
PASC
(Post-acute
sequelae
COVID-19)
symptoms
in
mental
health
have
up
to
date
not
been
comprehensively
examined.
Our
objective
is
provide
longitudinal
data
on
the
Post-COVID
patients
identify
risk
protective
factors
associated
with
a
severe
or
prolonged
course.
Methods:
Mental
265
outpatient
centre
University-Hospital
Erlangen
was
assessed
17.1
(T0)
22.5
months
after
infection
(T1).
An
online
survey
validated
questionnaires
for
(Post-COVID-Syndrome-Score),
depression
(Patient-Health-Questionnaire
9),
somatic
15),
anxiety
(Generalized-Anxiety-Disorder
7),
fatigue
(Fatigue-Severity-Scale)
Post-Exertional
Malaise
(PEM)
(DePaul
Post-Exertional-Malaise
Screening)
conducted
home
environment.
Results:
80%
experienced
at
follow
up.
Clinically
relevant
depression,
persistent
symptoms,
anxiety,
were
reported
by
55.8%,
72.5%,
18.9%
89.4%
respectively.
Depressive,
symptom
severity
decreased
significantly
over
time;
PEM
remained
an
unchanged
high
level.
Risk
factor
higher
scores
older
age;
prior
psychiatric
illness
treated
psychotherapy
more
depressive,
somatic,
symptoms.
longer
between
acute
initial
presentation
centre.
Conclusion:
findings
align
previous
research,
claiming
syndrome,
lasting
infection.
In-depth
assessment
implications
needed
planning
services
disease
prevention.